Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P09110
UPID:
THIK_HUMAN
Alternative names:
Acetyl-CoA C-myristoyltransferase; Acetyl-CoA acyltransferase; Beta-ketothiolase; Peroxisomal 3-oxoacyl-CoA thiolase
Alternative UPACC:
P09110; G5E935; Q96CA6
Background:
3-ketoacyl-CoA thiolase, peroxisomal, known alternatively as Acetyl-CoA C-myristoyltransferase, Acetyl-CoA acyltransferase, Beta-ketothiolase, and Peroxisomal 3-oxoacyl-CoA thiolase, plays a pivotal role in fatty acid peroxisomal beta-oxidation. It is responsible for the thiolytic cleavage of straight chain 3-keto fatty acyl-CoAs across various chain lengths, facilitating crucial steps in fatty acid metabolism.
Therapeutic significance:
Understanding the role of 3-ketoacyl-CoA thiolase, peroxisomal could open doors to potential therapeutic strategies.